Norimoto Hisayoshi
Chief Executive Officer bij PuraPharm Japan Corp.
Vermogen: 39 239 $ op 31-03-2024
Profiel
Norimoto Hisayoshi is currently the Chief Executive Officer at PuraPharm Japan Corp.
and also holds a position as General Manager at Sodx Co., Ltd.
His former positions include Executive Director at PuraPharm Corp.
Ltd., Head of Research & Development at Kracie Pharma Ltd.
and Kracie Pharmaceutical Ltd., Chief Research & Development Officer & GM at PuraPharm Corp.
Ltd., and General Manager at PuraPharm Japan Corp.
His education includes a doctorate and graduate degree from the University of Toyama.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PURAPHARM CORP. LTD.
0.09% | 31-12-2022 | 370 000 ( 0.09% ) | 39 239 $ | 31-03-2024 |
Actieve functies van Norimoto Hisayoshi
| Bedrijven | Functie | Begin |
|---|---|---|
Sodx Co., Ltd.
 Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Corporate Officer/Principal | - |
| PuraPharm Japan Corp. | Chief Executive Officer | 20-11-2023 |
Eerdere bekende functies van Norimoto Hisayoshi
| Bedrijven | Functie | Einde |
|---|---|---|
| PURAPHARM CORPORATION LIMITED | Director/Board Member | 20-11-2023 |
| Kracie Pharmaceutical Ltd. | Chief Tech/Sci/R&D Officer | 01-01-2016 |
Kracie Pharma Ltd.
 Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Chief Tech/Sci/R&D Officer | 01-01-2006 |
| PuraPharm Japan Corp. | Corporate Officer/Principal | - |
| PURAPHARM CORPORATION LIMITED | Chief Tech/Sci/R&D Officer | - |
Opleiding van Norimoto Hisayoshi
| University of Toyama | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PURAPHARM CORPORATION LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Kracie Pharma Ltd.
Kracie Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kracie Pharma Ltd. engages in the research and development of pharmaceutical products. It specializes in the manufacture and sale of kampo medicines and other related medicines for hospitals. The company was founded on May 1, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
| Kracie Pharmaceutical Ltd. | |
Sodx Co., Ltd.
Sodx Co., Ltd. Food RetailRetail Trade Part of PuraPharm Corp. Ltd., Sodx Co., Ltd. is a Japanese real estate company that specializes in condominium management and asset management. The company promises a safe and rich future that does not rely on public pensions through valuable real estate. The company aims to provide attractive condominiums with high asset value to realize a relaxed life. Sodx Co. was acquired by PuraPharm Corp. Ltd. on August 28, 2017 for $2.24 million. | Retail Trade |
| PuraPharm Japan Corp. |
